Market Research Report
Energy-Based Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024
|Published by||IMARC Services Private Limited||Product code||821304|
|Published||Content info||110 Pages
Delivery time: 2-3 business days
|Energy-Based Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024|
|Published: April 8, 2019||Content info: 110 Pages||
The global energy-based therapeutics market reached a value of US$ 6.1 Billion in 2018. Energy-based therapeutics are employed for the modification or destruction of tissues with the help of technologies such as microwave, thermal, hydro-mechanical, radiofrequency, cryotherapy, and ultrasound. These therapeutics are divided on the basis of clinical applications into general, ophthalmic and aesthetic surgeries. General surgeries include lithotripsy, gynecology, ENT microsurgery and surgery for cardiovascular diseases. Ophthalmic surgeries are often done for diseases like glaucoma and cataract. Aesthetic surgeries can be both invasive and non-invasive in nature and aid in reducing scars, acne, sun damage, pigmentation, redness and vascular lesions.
Breakthroughs in the field of aesthetic medicine have led to an increase in the adoption of energy-based aesthetic surgeries, especially for anti-aging treatments. Along with this, there has been a shift from invasive to non-invasive aesthetic procedures on a global level, owing to the affordability and efficacy of these therapies. Similarly, the increasing popularity of minimally invasive surgeries for the treatment of diseases like cardiac arrhythmias and cancer tumors, along with the benefits associated with these procedures like reduced complications, are creating a positive outlook for the global energy-based therapeutics market. Apart from this, the rising trend of physician-owned ambulatory surgical centers, also known as ASCs, is another key factor which is driving the market growth. Since most energy-based therapeutic procedures do not require hospital stays, surgeons across the world have started performing these therapies in their own clinics. On account of these factors, the market value is expected to reach more than US$ 8.9 Billion by 2024, at a CAGR of 6.4% during 2019-2024.
Aesthetic currently accounts for the largest share.
The report has also analysed the Competitive Landscape of the market with some of the key players being Johnson & Johnson, Lumenis, Syneron Medical, Abbott Medical Optics, Alcon, Alna Medical System, Angiodynamic, Angiodynamics, Atricure, Biolase, etc.